Tellgen Corp
SZSE:300642
Tellgen Corp
Cash from Financing Activities
Tellgen Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tellgen Corp
SZSE:300642
|
Cash from Financing Activities
-¥21.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Financing Activities
-¥2.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cash from Financing Activities
¥1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Financing Activities
-¥334.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cash from Financing Activities
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Financing Activities
-¥568.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Tellgen Corp's Cash from Financing Activities?
Cash from Financing Activities
-21.3m
CNY
Based on the financial report for Sep 30, 2023, Tellgen Corp's Cash from Financing Activities amounts to -21.3m CNY.
What is Tellgen Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
18%
Over the last year, the Cash from Financing Activities growth was 66%. The average annual Cash from Financing Activities growth rates for Tellgen Corp have been 18% over the past three years .